Vir is focused on creating novel therapeutics and vaccines for infectious diseases.

Their mission is to create a world without infectious diseases. Vir uses a platform approach combining in-house research, development, strategic acquisition and in-licensing to develop and scale five therapeutic platforms simultaneously which allows them to balance downside rise of investing in drug discovery.